The genome sequence of the human malaria parasite Plasmodium falciparum has been sequenced and analyzed, revealing a 23-megabase nuclear genome consisting of 14 chromosomes and encoding approximately 5,300 genes. This genome is the most (A + T)-rich sequenced to date, with a high proportion of genes dedicated to immune evasion and host-parasite interactions. Genes involved in antigenic variation are concentrated in subtelomeric regions. The genome encodes fewer enzymes and transporters compared to free-living eukaryotic microbes, but many nuclear-encoded proteins are targeted to the apicoplast, an organelle involved in fatty acid and isoprenoid metabolism. The genome sequence provides a foundation for future studies of this organism and is being used to search for new drugs and vaccines against malaria. Malaria remains a major public health threat, with over 300 million cases and 2.7 million deaths annually, predominantly in sub-Saharan Africa. The disease is caused by Plasmodium parasites, primarily P. falciparum, which is the most lethal species. Resistance to anti-malarial drugs and insecticides, along with environmental and social factors, contribute to the spread of malaria. The economic impact of malaria is significant, with malaria-endemic countries experiencing lower growth rates compared to non-malarious countries. An international effort was launched in 1996 to sequence the P. falciparum genome, leading to the publication of sequences for several chromosomes. The genome was sequenced using a whole chromosome shotgun approach, with challenges in gap closure due to the high (A + T) content. The genome contains 22.8 megabases distributed among 14 chromosomes, with a high (A + T) content of 80.6%. The genome encodes a full set of tRNA genes and has a unique tRNA structure. The mitochondrial genome is small and does not encode tRNAs, requiring import from the cytoplasm. The apicoplast genome encodes sufficient tRNAs for protein synthesis within the organelle. The P. falciparum genome contains a large number of genes, with approximately 5,300 protein-encoding genes. Many of these genes are unique to this organism, and a significant proportion have unknown functions. The genome includes genes involved in various metabolic pathways, including fatty acid and isoprenoid synthesis, as well as haem biosynthesis. The genome also encodes enzymes involved in DNA replication, repair, and recombination, with some components of major DNA repair processes found in other eukaryotes. The genome sequence has provided insights into the biology of P. falciparum, including its metabolism, transport, and immune evasion mechanisms. The parasite's ability to evade the host immune system is a key factor in its pathogenicity.The genome sequence of the human malaria parasite Plasmodium falciparum has been sequenced and analyzed, revealing a 23-megabase nuclear genome consisting of 14 chromosomes and encoding approximately 5,300 genes. This genome is the most (A + T)-rich sequenced to date, with a high proportion of genes dedicated to immune evasion and host-parasite interactions. Genes involved in antigenic variation are concentrated in subtelomeric regions. The genome encodes fewer enzymes and transporters compared to free-living eukaryotic microbes, but many nuclear-encoded proteins are targeted to the apicoplast, an organelle involved in fatty acid and isoprenoid metabolism. The genome sequence provides a foundation for future studies of this organism and is being used to search for new drugs and vaccines against malaria. Malaria remains a major public health threat, with over 300 million cases and 2.7 million deaths annually, predominantly in sub-Saharan Africa. The disease is caused by Plasmodium parasites, primarily P. falciparum, which is the most lethal species. Resistance to anti-malarial drugs and insecticides, along with environmental and social factors, contribute to the spread of malaria. The economic impact of malaria is significant, with malaria-endemic countries experiencing lower growth rates compared to non-malarious countries. An international effort was launched in 1996 to sequence the P. falciparum genome, leading to the publication of sequences for several chromosomes. The genome was sequenced using a whole chromosome shotgun approach, with challenges in gap closure due to the high (A + T) content. The genome contains 22.8 megabases distributed among 14 chromosomes, with a high (A + T) content of 80.6%. The genome encodes a full set of tRNA genes and has a unique tRNA structure. The mitochondrial genome is small and does not encode tRNAs, requiring import from the cytoplasm. The apicoplast genome encodes sufficient tRNAs for protein synthesis within the organelle. The P. falciparum genome contains a large number of genes, with approximately 5,300 protein-encoding genes. Many of these genes are unique to this organism, and a significant proportion have unknown functions. The genome includes genes involved in various metabolic pathways, including fatty acid and isoprenoid synthesis, as well as haem biosynthesis. The genome also encodes enzymes involved in DNA replication, repair, and recombination, with some components of major DNA repair processes found in other eukaryotes. The genome sequence has provided insights into the biology of P. falciparum, including its metabolism, transport, and immune evasion mechanisms. The parasite's ability to evade the host immune system is a key factor in its pathogenicity.